title: Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment.
abstract: Forkhead box p3 (Foxp3) expression was believed to be specific for T-regulatory cells but has recently been described in non-hematopoietic cells from different tissue origins and in tumor cells from both epithelial and non-epithelial tissues. The aim of this study was to elucidate the role of Foxp3 in murine melanoma. The B16F10 cell line Foxp3 silenced with small interference Foxp3 plasmid transfection was established and named B16F10.1. These cells had lower levels of Foxp3 mRNA (quantitative real-time reverse transcription-polymerase chain reaction [0.235-fold]), protein (flow cytometry [0.02%]), CD25(+) expression (0.06%), cellular proliferation (trypan blue staining), and interleukin (IL)-2 production (enzyme-linked immunosorbent assay [72.35 pg/mL]) than those in B16F10 wild-type (WT) cells (P<0.05). Subcutaneous inoculation of the B16F10.1 cell line into C57BL/6 mice delayed the time of visible tumor appearance, increased the time of survival, and affected the weight of tumors, and also decreased the production of IL-10, IL-2, and transforming growth factor beta compared with mice inoculated with the B16F10 WT cell line. The B16F10.1 cells derived from tumors and free of T-cells (isolated by Dynabeads and plastic attachment) expressed relatively lower levels of Foxp3 and CD25(+) than B16F10 WT cells (P<0.05) in a time-dependent manner. The population of tumor-infiltrating lymphocytes of T CD4(+) cells (CD4(+), CD4(+)CD25(+), and CD4(+)CD25(+)Foxp3(+)) increased in a time-dependent manner (P<0.05) in tumors derived from B16F10 WT cells and decreased in tumors derived from B16F10.1 cells. Similar data were obtained from spleen cells. These results suggest that, in melanomas, Foxp3 partly induces tumor growth by modifying the immune system at the local and peripheral level, shifting the environment toward an immunosuppressive profile. Therapies incorporating this transcription factor could be strategies for cancer treatment.
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Moisés A
authors.initials: MA
authors.lastname: Franco-Molina
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Diana F
authors.initials: DF
authors.lastname: Miranda-Hernández
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Edgar
authors.initials: E
authors.lastname: Mendoza-Gamboa
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Pablo
authors.initials: P
authors.lastname: Zapata-Benavides
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Erika E
authors.initials: EE
authors.lastname: Coronado-Cerda
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Crystel A
authors.initials: CA
authors.lastname: Sierra-Rivera
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Santiago
authors.initials: S
authors.lastname: Saavedra-Alonso
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Reyes S
authors.initials: RS
authors.lastname: Taméz-Guerra
authors.affiliation: Immunology and Virology Department, Biological Sciences Faculty, University Autonoma of Nuevo León (UANL), San Nicolás de los Garza, Nuevo León, Mexico.
authors.forename: Cristina
authors.initials: C
authors.lastname: Rodríguez-Padilla
keywords: Foxp3; T-regulatory cells; cancer; melanoma
references.citation: Blood. 2008 Apr 1;111(7):3599-606
references.pmid: 18223166
references.citation: Cancer Res. 2007 Sep 1;67(17):8344-50
references.pmid: 17804750
references.citation: Int J Clin Exp Med. 2015 Feb 15;8(2):1792-802
references.pmid: 25932107
references.citation: J Pathol. 2014 Sep;234(1):74-85
references.pmid: 24870556
references.citation: Discov Med. 2010 Oct;10(53):322-8
references.pmid: 21034673
references.citation: J Immunother. 2007 Apr;30(3):294-302
references.pmid: 17414320
references.citation: Blood. 2008 Dec 15;112(13):4953-60
references.pmid: 18820132
references.citation: Cancer Immunol Immunother. 2011 Aug;60(8):1109-18
references.pmid: 21547596
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
references.pmid: 16617117
references.citation: Cancer Res. 2009 Mar 15;69(6):2252-9
references.pmid: 19276356
references.citation: Eur J Immunol. 2011 Feb;41(2):503-13
references.pmid: 21268019
references.citation: J Cell Physiol. 2013 Jan;228(1):30-5
references.pmid: 22674548
references.citation: Br J Cancer. 2014 Mar 18;110(6):1552-60
references.pmid: 24548868
references.citation: Cancer Res. 2008 Apr 15;68(8):3001-9
references.pmid: 18413770
references.citation: J Exp Med. 2007 Aug 6;204(8):1757-64
references.pmid: 17620361
references.citation: Oncol Lett. 2013 Nov;6(5):1195-1200
references.pmid: 24179494
references.citation: J Transl Med. 2008 Apr 22;6:19
references.pmid: 18430198